Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double‐blind, 12‐week, flexible‐dose, placebo‐controlled erectile dysfunction clinical trial - Concepedia

Concepedia

Publication | Closed Access

Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double‐blind, 12‐week, flexible‐dose, placebo‐controlled erectile dysfunction clinical trial

69

Citations

28

References

2004

Year

Culley C. Carson, Dimitrios Hatzichristou, Serge Carrier, Douglas Lording, Peter Lyngdorf, Philip J. Aliotta, Stephen M. Auerbach, Myron Murdock, H. Jeffrey Wilkins, Trish A. McBride,

British Journal of Urology

Abstract

Vardenafil is an effective and generally safe treatment for ED, even in men unresponsive to sildenafil (by history).

References

	Year	Citations

Page 1